Skip to Content

AngioLab Inc 251280 Stock Quote

| Rating as of

Morningstar‘s Stock Analysis 251280

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics 251280

Company Profile 251280

Business Description

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

65 Techno 3ro, Suite 159
Doejeon, China, People's Republic of
T +86 428675785
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Dec 31, 2018
Stock Type
Employees 14